Exclusive: Cancer drugmaker Tesaro attracts takeover interest - sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/11/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- AppLovin gains market share among e-commerce advertisers
- Wall Street ends higher as investors turn to earnings season
Leerink Partners Downgrades Tesaro (TSRO) to Market Perform
February 10, 2017 6:51 AM ESTLeerink Partners downgraded Tesaro (NASDAQ: TSRO) from Outperform to Market Perform with a price target of $186.00 (from $152.00).
For an analyst ratings summary and ratings history on Tesaro click here. For more ratings news on Tesaro click here.
Shares of Tesaro closed at $186.91 yesterday.
... MoreTESARO (TSRO) may be worth $250/share in sale, Bloomberg citing SunTrust
February 8, 2017 1:07 PM ESTTESARO (NASDAQ: TSRO) may be worth $250/share in sale, Bloomberg citing SunTrust.
... More